Synergy Pharmaceuticals Inc.Company Review & Valuation

SGYP
Nasdaq

About Synergy Pharmaceuticals Inc.

Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat gastrointestinal diseases and disorders. Its lead product is plecanatide, a novel uroguanylin based gastrointestinal platform that is traded under the TRULANCE nameShow more for the treatment of chronic idiopathic constipation and irritable bowel syndrome. The company also develops dolcanatide to treat mild-to-moderate ulcerative colitis. It has a licensing agreement with Cipher Pharmaceuticals Inc. to develop, market, distribute, and sell TRULANCE in Canada. Synergy Pharmaceuticals Inc. is headquartered in New York, New York.Show less

Industry
Drug Manufacturers - Specialty & Generic
HQ Location
New York, New York

Stock Price

Price data not available for Synergy Pharmaceuticals Inc..

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

Evotec AG
OPKO Health
BioGaia
STADA Arzneimittel

back to top